First-in-Man Trial of SiO<sub>2</sub> Inert-Coated Bare Metal Stent System in Native Coronary Stenosis ― The AXETIS FIM Trial ―
Taku Asano(Amsterdam UMC Location University of Amsterdam), Yoshinobu Onuma(Ollscoil na Gaillimhe – University of Galway), Joanna J. Wykrzykowska(University Medical Center Groningen), Yosuke Miyazaki(Yamaguchi University), Yohei Sotomi(Kyoto University), Patrick W. Serruys(Erasmus MC), Mariann Gyöngyösi(Medical University of Vienna), Robin P. Kraak(Amsterdam UMC Location University of Amsterdam), Yuki Katagiri(University of Amsterdam), Pannipa Suwannasom(Amsterdam UMC Location University of Amsterdam), Benno J. Rensing(St. Antonius Ziekenhuis), Jan J. Piek(Amsterdam University Medical Centers)
Cited by 5
Related Papers
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
|New England Journal of Medicine|2002|4k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
2024 ESC Guidelines for the management of chronic coronary syndromes
|European Heart Journal|2024|2.3k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k